Alerts will be sent to your verified email
Verify Email
ZENOTECH
|
Zenotech Laboratorie
|
Wintac
|
Panacea Biotec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.34 % | 78.06 % | 19.34 % |
|
5yr average Equity Multiplier
|
1.38 | -4.32 | 2.01 |
|
5yr Average Asset Turnover Ratio
|
0.31 | 0.65 | 0.39 |
|
5yr Avg Net Profit Margin
|
-13.36 % | -8.7 % | 20.95 % |
|
Price to Book
|
4.1 | 0.0 | 0.97 |
|
P/E
|
44.75 | 193.85 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
31.2 Days | -191.8 Days | -83.17 Days |
|
Inventory Days
|
145.01 Days | 77.6 Days | 118.8 Days |
|
Days Receivable
|
61.38 Days | 24.76 Days | 54.62 Days |
|
Days Payable
|
477.06 Days | 266.89 Days | 284.35 Days |
|
5yr Average Interest Coverage Ratio
|
-4.03 | -2.44 | 2.91 |
|
5yr Avg ROCE
|
7.48 % | 22.62 % | -10.17 % |
|
5yr Avg Operating Profit Margin
|
11.69 % | 0.23 % | -2.87 % |
|
5 yr average Debt to Equity
|
0.2 | -2.95 | 0.41 |
|
5yr CAGR Net Profit
|
n/a | n/a | n/a |
|
5yr Average Return on Assets
|
7.92 % | -5.26 % | 7.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.84 % | 54.99 % | 73.59 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -1.27 % |
|
Zenotech Laboratorie
|
Wintac
|
Panacea Biotec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|